China Pharma Holdings, Inc. (CPHI)

China Pharma Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.84	1.42	2.03	4.86	0.96	1.18
Short-Term Investments	0	0.07	0.01	0.09	0.05	0.05
Cash & Cash Equivalents	0.84	1.49	2.04	4.95	1.01	1.23
Cash Growth	-30.19%	-27.11%	-58.72%	389.47%	-17.82%	-50.40%
Receivables	0.4	0.66	0.9	0.74	0.53	0.68
Inventory	3.68	3.73	2.95	3.34	3.71	3.59
Other Current Assets	0.2	0.11	0.08	0.06	0.07	0.08
Total Current Assets	5.12	6	5.96	9.09	5.32	5.58
Property, Plant & Equipment	6.55	7.22	10.01	13.41	15.61	16.45
Goodwill and Intangibles	4.52	3.26	1.81	0.15	0.18	0.21
Total Long-Term Assets	11.07	10.47	11.82	13.56	15.8	16.66
Total Assets	16.19	16.47	17.78	22.65	21.12	22.24
Accounts Payable	2.77	3.25	3.06	2.81	3.98	4.93
Current Debt	2.74	3.18	8.76	7.19	6.52	4.42
Other Current Liabilities	0.23	0.39	0.93	0.51	0.9	0.7
Total Current Liabilities	5.73	6.82	12.74	10.51	11.4	10.05
Long-Term Debt	1.43	1.45	0	5.29	0.9	2.2
Other Long-Term Liabilities	0.74	0.74	0.75	0.82	0.81	0.75
Total Long-Term Liabilities	2.17	2.19	0.75	6.12	1.71	2.95
Total Liabilities	7.9	9.01	13.49	16.63	13.11	13
Total Debt	4.17	4.63	8.76	12.49	7.43	6.62
Debt Growth	-51.85%	-47.08%	-29.88%	68.12%	12.17%	-15.30%
Retained Earnings	-40.25	-39.29	-36.21	-32.24	-28.84	-25.97
Comprehensive Income	11.43	11.45	11.57	12.56	12.35	11.58
Shareholders' Equity	8.29	7.45	4.29	6.02	8	9.24
Net Cash / Debt	-3.33	-3.14	-6.71	-7.54	-6.42	-5.39
Net Cash Per Share	-0.25	-0.93	-6.39	-8.17	-7.35	-6.19
Working Capital	-0.6	-0.82	-6.77	-1.42	-6.08	-4.47
Book Value Per Share	0.63	2.20	4.08	6.52	9.18	10.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).